Neuroblastoma is one of the most common solid cancers in children. We present the data collected for the EUROCARE II study, describing survival patterns for children diagnosed in Europe 1985-1989 in detail: and exploring time trends from 1978 to 1992. On average, the mean 5-year survival rate was considerably higher in infants (79%) compared with older children (30-33%). The risk of death has dropped by 37% from 1978-1981 to 1990-1992. There is a pronounced difference between countries, with Scotland and England and Wales having two of the lowest survival rates (28% (95% confidence interval (CI) 14048) and 36% (95% CI 31-41) 5-year survival rates, respectively). The survival rates in France, Germany and Italy (48-66% 5-year survival rate) w...
Population-based studies on childhood cancer survival are key to monitor progress against cancer and...
PURPOSE: Long-term trends in neuroblastoma incidence and survival in unscreened populations are unkn...
Population-based studies on childhood cancer survival are key to monitor progress against cancer and...
Abstract Neuroblastoma is one of the most common solid cancers in children. We present the data coll...
Abstract The Automated Childhood Cancer Information System (ACCIS) collects and presents data on chi...
Abstract PURPOSE: EUROCARE collected data from population-based cancer registries in 20 European cou...
Abstract EUROCARE is a population-based survival study including data from European Cancer Registrie...
Purpose To describe treatment, clinical course, and survival of a cohort of Italian patients with n...
Background Neuroblastoma is a major contributor to childhood cancer mortality, but its prognosis var...
Background. In the last decades, prognosis of children with neuroblastoma has improved only slightly...
Abstract This study, originating in the Automated Childhood Cancer Information System (ACCIS), evalu...
The aim of this study was to provide a comparative description of geographical variations and time t...
Background: EUROCARE-3 collected data from 45 population-based cancer registries in 20 countries on ...
The aim of this study was to provide a comparative description of geographical variations and time t...
The aim of this study was to provide a comparative description of geographical variations and time t...
Population-based studies on childhood cancer survival are key to monitor progress against cancer and...
PURPOSE: Long-term trends in neuroblastoma incidence and survival in unscreened populations are unkn...
Population-based studies on childhood cancer survival are key to monitor progress against cancer and...
Abstract Neuroblastoma is one of the most common solid cancers in children. We present the data coll...
Abstract The Automated Childhood Cancer Information System (ACCIS) collects and presents data on chi...
Abstract PURPOSE: EUROCARE collected data from population-based cancer registries in 20 European cou...
Abstract EUROCARE is a population-based survival study including data from European Cancer Registrie...
Purpose To describe treatment, clinical course, and survival of a cohort of Italian patients with n...
Background Neuroblastoma is a major contributor to childhood cancer mortality, but its prognosis var...
Background. In the last decades, prognosis of children with neuroblastoma has improved only slightly...
Abstract This study, originating in the Automated Childhood Cancer Information System (ACCIS), evalu...
The aim of this study was to provide a comparative description of geographical variations and time t...
Background: EUROCARE-3 collected data from 45 population-based cancer registries in 20 countries on ...
The aim of this study was to provide a comparative description of geographical variations and time t...
The aim of this study was to provide a comparative description of geographical variations and time t...
Population-based studies on childhood cancer survival are key to monitor progress against cancer and...
PURPOSE: Long-term trends in neuroblastoma incidence and survival in unscreened populations are unkn...
Population-based studies on childhood cancer survival are key to monitor progress against cancer and...